Get to Know Us

---

Clinical cardiologist, with over 30 years of practice and industry experience. He has had a distinguished career in pharma, diagnostics and device industries. He has had four drug launches, Lovaza, Cardene IV, Multaq and Vascepa. He held positions as Chief Clinical Officer for Atherotech Diagnostics and then Executive Director of Medical Affairs for Quest Diagnostics. He has consulted in the device and pharma industry since 2018 and is CMO for Inomagen Therapeutics and iMedrix Diagnostics.

Louis is a seasoned operations and business leader with 25+ years of experience driving growth and operational excellence across the medical, homeland security, and manufacturing industries. As Director of Operations, he oversees manufacturing, packaging, and distribution, ensuring seamless execution. Previously, as a Partner in a homeland security solutions firm, he led PPE projects, leveraging expertise in manufacturing, sales, and distribution for medical and security sectors. Earlier, as Founder, COO, and CFO of Global Protection USA and Global Medical, a protective equipment and medical supply company respectively, he scaled revenue to $70m annually, managing $600m+ in total revenue and leading 100+ employees over 14 years. With deep financial acumen, global perspective, and leadership expertise, Louis has consistently driven innovation and operational success.

Jeff has over 33 years of legal experience with law firms as well as in-house with public, privately held, PE backed, pre- IPO and start-up ventures in a variety of manufacturing and technology businesses. He is an experienced C-Suite professional who also holds an MBA from Duke University and is adept at crafting business as well as legal solutions. He brings a strong skillset in governance and public company readiness having been involved with SPAC and IPO transactions. His business acumen led to an appointment as the CEO of a multi-billion- dollar tech company before joining the iMedrix Board and he now serves as the General Counsel and Chief Administrative Officer of iMXD and now Evolve Bioplastics.

Dr. Ellenbogen is Pauley Heart Center's Kimmerling Prof of Medicine and the Director of Clinical Cardiac Electrophysiology and Pacing on the MCV Campus. Undergrad of Princeton University, earned his M.D. from Johns Hopkins University, where he also did his internship and residency training in Internal Medicine then his Cardiology fellowship training at Duke University. He has been at the Medical College of Virginia since 1986, a full professor since 1997. He is Director of Clinical Cardiac Electrophysiology and Pacing at VCU. He is immediate past president of the Heart Rhythm Society. He has published more than 350 original scientific reports and over 200 book chapters, editorials, and review articles. He has been an advisor for many medical device and pharma companies.

Gregg Sutton is a veteran medical device entrepreneur and developer who has founded/cofounded several device companies which have produced multiple market leading devices. He held the position of Vice President, Research & Development at Surmodics, Inc. (2016-2020) a medical device technology company that acquired NorMedix in 2016. Founder and President/CEO of NorMedix he started in 2010. Mr. Sutton was co-founder of, and held the position of VP Research & Development at Atritech, Inc., a Minneapolis based company, where he led the development of the Watchman LAA Occlusion Device which was acquired by Boston Scientific in 2010. Prior to Atritech, Mr. Sutton held executive positions at Vascular Solutions, Inc., Angioguard, Inc. (acquired by J&J 1999), and Navarre Biomedical, Inc. (co-founder, acquired by CR Bard 1997). Mr. Sutton has over 30 years in the medical device field and has over 60 patents granted and pending. Gregg has a degree in Mechanical Engineering from the University of Minnesota.